Labcorp (LH)
(Delayed Data from NYSE)
$234.38 USD
+5.27 (2.30%)
Updated Nov 6, 2024 04:00 PM ET
After-Market: $234.35 -0.03 (-0.01%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth D Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$234.38 USD
+5.27 (2.30%)
Updated Nov 6, 2024 04:00 PM ET
After-Market: $234.35 -0.03 (-0.01%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth D Momentum C VGM
Zacks News
LabCorp, Philips Tie Up to Advance in Digital Pathology
by Zacks Equity Research
Through the latest collaboration, LabCorp (LH) aims at strengthening its hold inthe high potential digital pathology market.
Why You Should Retain Quest Diagnostics in Your Portfolio
by Zacks Equity Research
Quest Diagnostics (DGX) reveals both sides of the same coin, reflecting its bleak aspects plaguing the stock as well as projecting its brighter side to denote a near-term rebound.
Why Is Laboratory of America Holdings (LH) Up 1.7% Since Its Last Earnings Report?
by Zacks Equity Research
Laboratory of America Holdings (LH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
LabCorp (LH) Beats on Earnings & Revenues in Q1
by Zacks Equity Research
Here we have highlighted some of the key details from the just-released earnings report of Laboratory Corp. of America Holdings (LH).
LabCorp Forms Lab-Alliance With Kentucky-Based Health Firm
by Zacks Equity Research
The multi-year, comprehensive laboratory deal to help LabCorp (LH) provide high-quality, high-value and standardized laboratory diagnostics for Appalachian Regional Healthcare.
Is Laboratory Corporation (LH) a Great Stock for Value Investors?
by Zacks Equity Research
Is Laboratory Corporation (LH) a great pick from the value investor's perspective right now? Read on to know more.
LabCorp (LH) Up 1.1% Since Earnings Report: Can It Continue?
by Zacks Equity Research
LabCorp (LH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
LabCorp (LH) Tops Q4 Earnings & Misses Revenue Estimates
by Zacks Equity Research
LabCorp (LH) witnessed year over year growth in net revenue on the back of both LabCorp Diagnostics and Covance Drug Development segment in Q4.
LabCorp (LH) Beats on Q3 Earnings & Revenue Estimates
by Zacks Equity Research
LabCorp (LH) rides high on both LabCorp Diagnostics segment and Covance Drug Development segment in Q3.
What's in the Cards for LabCorp (LH) This Earnings Season?
by Zacks Equity Research
LabCorp (LH) might gain from continued growth in its companion diagnostics portfolio in Q3.
Should Value Investors Pick Laboratory Corporation (LH) Stock?
by Zacks Equity Research
Is Laboratory Corporation (LH) a great pick from the value investor's perspective right now? Read on to know more.
LabCorp Completes $1.2-Billion Chiltern Buyout, Boosts CRO
by Zacks Equity Research
In line with its inorganic growth strategy, LabCorp's (LH) latest Chiltern buyout is aimed at promoting the CRO business.
LabCorp (LH) Beats on Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Laboratory Corp. of America Holdings (LH) rides high on its Diagnostics business Q2. The raised outlook buoys optimism.
LabCorp (LH) Tops Q1 Earnings, Misses Revenue Estimate
by Urmimala Biswas
LabCorp has a Zacks Rank #4(Sell) but that could change following its first quarter 2017 earnings report which has just released.
Is Laboratory Corp. a Suitable Stock For Value Investors?
by Zacks Equity Research
Let's put Laboratory Corporation Of America Holdings (LH) stock into this equation and find out if it is a good choice for value-oriented investors right now.
LabCorp (LH) Up 3.6% Since Earnings Report: Can It Continue?
by Zacks Equity Research
LabCorp (LH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
LabCorp (LH) Beats on Q4 Earnings & Revenue Estimates
by Zacks Equity Research
LabCorp posted fourth quarter 2016 results with both earnings and revenues beating the Zacks Consensus Estimate.
MedTech Stocks' Q4 Earnings on Feb 16: LH, WST and MDRX
by Zacks Equity Research
Let's take a look at the major MedTech stocks slated to release their fourth-quarter 2016 numbers on Feb 16.
Lots Happening in MedTech: Should You Buy These Stocks?
by Zacks Equity Research
We have noticed a substantial transformation in the U.S. medical device market of late and it is important for market participants to adapt. We have hit upon3 major evolving trends in this sector.
3 Stocks That Beat Earnings and Raised This Week
by Brian Bolan
The beat and raise is music to the ears of the aggressive growth investor.